Literature DB >> 3552706

Characteristics of the P2 purinoceptor that mediates prostacyclin production by pig aortic endothelial cells.

L Needham, N J Cusack, J D Pearson, J L Gordon.   

Abstract

Release of prostacyclin was studied by superfusing small columns containing cells cultured on microcarrier beads. Transient dose-dependent stimulation of prostacyclin release by up to 500-fold was induced by adenosine 5'-triphosphate (ATP; 0.5-50 microM). Adenosine 5'-diphosphate (ADP) gave similar responses, whereas adenosine 5'-phosphate (AMP) and adenosine were essentially inactive. Of other natural nucleotides tested only uridine 5'-phosphate (UTP) was active. The L-enantiomers of ATP and ADP were inactive. 2-Cl-ATP was approximately 100 times more potent than ATP; 2-MeS-ATP was also more potent (threshold 0.05 microM) but its maximal effectiveness was less than 20% that of ATP; 2-EtS-ATP had a similar threshold to ATP but was even less effective than 2-MeS-ATP. Phosphorothioate nucleotide analogues of ATP or ADP were active, with no stereoselectivity between Rp and Sp diastereoisomers. No analogue tested showed antagonist activity. We conclude that ATP mediates endothelial prostacyclin release apparently via a P2Y receptor, although there are some striking differences from the previously described P2Y receptor mediating endothelium-dependent vasodilation in pig aorta.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552706     DOI: 10.1016/0014-2999(87)90166-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  36 in total

1.  Mechanisms of coronary vasodilatation produced by ATP in guinea-pig isolated perfused heart.

Authors:  I P Brown; C I Thompson; F L Belloni
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Study of the mechanisms involved in adenosine-5'-O-(2-thiodiphosphate) induced relaxation of rat thoracic aorta and pancreatic vascular bed.

Authors:  B Saïag; D Hillaire-Buys; J Chapal; P Petit; D Pape; B Rault; H Allain; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Kinetics of extracellular ATP hydrolysis by microvascular endothelial cells from rat heart.

Authors:  P Meghji; J D Pearson; L L Slakey
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

4.  Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens.

Authors:  I von Kügelgen; E Schöffel; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

5.  Effects of amiloride analogues on the production of prostacyclin by aortic endothelial cells.

Authors:  J M Boeynaems; D Demolle; C Lagneau; E J Cragoe
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

6.  Effects of changes in extra- and intracellular K+ on the endothelial production of prostacyclin.

Authors:  J M Boeynaems; I Ramboer
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

7.  Effects of P1 and P2Y purinoceptor antagonists on endothelium-dependent and -independent relaxations of rat mesenteric artery to GTP and guanosine.

Authors:  P Vuorinen; X Wu; P Arvola; H Vapaatalo; I Pörsti
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Evidence for a nucleotide receptor on adrenal medullary endothelial cells linked to phospholipase C and phospholipase D.

Authors:  J R Purkiss; G F Wilkinson; M R Boarder
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

9.  Actions of ADP, but not ATP, on cytosolic free Ca2+ in single rat hepatocytes mimicked by 2-methylthioATP.

Authors:  C J Dixon; P H Cobbold; A K Green
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Direct modulation of GABAA receptor by intracellular ATP in dissociated nucleus tractus solitarii neurones of rat.

Authors:  T Shirasaki; K Aibara; N Akaike
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.